1. Home
  2. GECC vs FORA Comparison

GECC vs FORA Comparison

Compare GECC & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GECC

Great Elm Capital Corp.

HOLD

Current Price

$6.14

Market Cap

79.9M

Sector

Finance

ML Signal

HOLD

Logo Forian Inc.

FORA

Forian Inc.

HOLD

Current Price

$2.17

Market Cap

67.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GECC
FORA
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Computer Software: Prepackaged Software
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
79.9M
67.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GECC
FORA
Price
$6.14
$2.17
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
91.0K
45.0K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
22.06%
N/A
EPS Growth
N/A
25.00
EPS
N/A
N/A
Revenue
N/A
$30,256,919.00
Revenue This Year
$0.92
$8.44
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.13
52 Week Low
$4.63
$1.64
52 Week High
$11.45
$2.71

Technical Indicators

Market Signals
Indicator
GECC
FORA
Relative Strength Index (RSI) 60.87 64.06
Support Level $5.40 $2.05
Resistance Level $7.16 $2.20
Average True Range (ATR) 0.27 0.01
MACD 0.02 -0.00
Stochastic Oscillator 82.78 66.67

Price Performance

Historical Comparison
GECC
FORA

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: